ATE346057T1 - Sorbicillacton-a-derivate zur behandlung von tumor- und viruserkrankungen - Google Patents

Sorbicillacton-a-derivate zur behandlung von tumor- und viruserkrankungen

Info

Publication number
ATE346057T1
ATE346057T1 AT03797201T AT03797201T ATE346057T1 AT E346057 T1 ATE346057 T1 AT E346057T1 AT 03797201 T AT03797201 T AT 03797201T AT 03797201 T AT03797201 T AT 03797201T AT E346057 T1 ATE346057 T1 AT E346057T1
Authority
AT
Austria
Prior art keywords
derivatives
alkyl
sorbicillactone
tumor
treatment
Prior art date
Application number
AT03797201T
Other languages
German (de)
English (en)
Inventor
Gerhard Bringmann
Gerhard Lang
Joerg Muehlbacher
Karsten Schaumann
Stefan Steffens
Werner E G Mueller
Original Assignee
Univ Mainz Johannes Gutenberg
Bayern Freistaat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mainz Johannes Gutenberg, Bayern Freistaat filed Critical Univ Mainz Johannes Gutenberg
Application granted granted Critical
Publication of ATE346057T1 publication Critical patent/ATE346057T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
AT03797201T 2002-08-21 2003-07-17 Sorbicillacton-a-derivate zur behandlung von tumor- und viruserkrankungen ATE346057T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10238257A DE10238257B4 (de) 2002-08-21 2002-08-21 Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE346057T1 true ATE346057T1 (de) 2006-12-15

Family

ID=31501834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03797201T ATE346057T1 (de) 2002-08-21 2003-07-17 Sorbicillacton-a-derivate zur behandlung von tumor- und viruserkrankungen

Country Status (9)

Country Link
US (1) US20060111420A1 (enExample)
EP (1) EP1532129B1 (enExample)
JP (1) JP2006503049A (enExample)
AT (1) ATE346057T1 (enExample)
AU (1) AU2003250985A1 (enExample)
CA (1) CA2496386A1 (enExample)
DE (2) DE10238257B4 (enExample)
WO (1) WO2004026854A1 (enExample)
ZA (1) ZA200502226B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004004901B4 (de) * 2004-01-30 2006-01-05 Johannes-Gutenberg-Universität Mainz Verfahren zur Herstellung von Sorbicillacton A
DE102004005106A1 (de) * 2004-02-02 2005-08-18 Johannes-Gutenberg-Universität Mainz Sorbifuranone, Sorbivineton, Sorbivinetol und Derivate dieser Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung
KR102438137B1 (ko) 2015-12-02 2022-08-30 에스케이이노베이션 주식회사 내열성 및 셧다운 특성이 우수한 이차전지용 분리막
CN110037054B (zh) * 2019-04-16 2021-04-20 云南大学 一种提高烟草抗病性的水溶性多肽诱导剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use
AU2001293048A1 (en) * 2000-09-26 2002-04-08 The Johns Hopkins University Antiviral compositions and methods of use

Also Published As

Publication number Publication date
DE10238257B4 (de) 2007-04-19
JP2006503049A (ja) 2006-01-26
DE50305776D1 (de) 2007-01-04
AU2003250985A1 (en) 2004-04-08
US20060111420A1 (en) 2006-05-25
EP1532129B1 (de) 2006-11-22
WO2004026854A1 (de) 2004-04-01
CA2496386A1 (en) 2004-04-01
EP1532129A1 (de) 2005-05-25
DE10238257A1 (de) 2004-03-11
ZA200502226B (en) 2006-02-22

Similar Documents

Publication Publication Date Title
JOP20220069A1 (ar) عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
MA32175B1 (fr) Oxadiazoanthracènes pour le traitement du diabète
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
EA201290260A1 (ru) Бензимидазол-имидазольные производные
IS8395A (is) Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
EA200601620A1 (ru) 5,6-диалкил-7-аминотриазолопиримидины, способ их получения и их применение для борьбы с патогенными растениями, а также содержащие их средства
BRPI0507005A (pt) compostos, composições farmacêuticas, uso de um composto, e, método de preparo de uma composição farmacêutica
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
ATE517861T1 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
HUP0402616A2 (hu) Bifenilmetil-tiazolidindionok, bifenilpropionsav-származékok, alkalmazásuk PPAR-gamma aktivátorként és az ezeket tartalmazó gyógyszerészeti és kozmetikai készítmények
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE331713T1 (de) Verfahren zur herstellung von 5-nitrobenzofuranen
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
CY1109376T1 (el) Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης
AR115698A1 (es) Tieniloxazolonas y análogos de las mismas
SE0402925D0 (sv) Novel Compounds
MA31742B1 (fr) Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
SE0300091D0 (sv) Novel compounds
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
SE0300092D0 (sv) Novel compounds
BR0015364A (pt) 5-benzil-2,4-diaminopirimidinas substituìdas
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee